Myo-Inositol Trispyrophosphate (ITPP) Tablets
Myo-Inositol Trispyrophosphate (ITPP) is a phosphorylated derivative of inositol that has attracted attention for its potential therapeutic applications, particularly in enhancing oxygen delivery in tissues by modifying hemoglobin’s affinity for oxygen. It may also play a role in cancer research by inhibiting tumor growth through metabolic pathway modulation and has been studied for its neuroprotective effects in neurodegenerative conditions.
| Myo-Inositol Trispyrophosphate | |
| CAS Number | 623552-11-4 |
| Molar Mass | 605.984 g/mol |
| Chemical Formula | C6H12O21P6 |
| IUPAC Name | 4,6,11,13,18,20-hexahydroxy-3,5,7,10,12,14,17,19,21-nonaoxa-4λ5,6λ5,11λ5,13λ5,18λ5,20λ5-hexaphosphatetracyclo[14.5.0.02,8.09,15]henicosane 4,6,11,13,18,20-hexaoxide |
In the category of Nootropics tablets, Iron Mountain Labz also offers unifiram,, and more.

A Door of Hope
Aromatase Inhibitors: Understanding Estrogen Control in Modern Research
Inside SARMs: What They Are, How They Work, And Why They’re Studied
PDE5 Inhibitors: Unlocking the Science of Sexual Performance & Vascular Health Research
Post-Cycle Therapy: A Researcher’s Guide to Hormonal Recovery & Balance
Prohormones: A Scientific Guide to Hormonal Research Compounds
Research Peptides: Mechanisms, Methods, and Molecular Potential
The Science of SERMs: Receptor Binding, Selectivity, and Research Potential
Unlocking the Mind – A Comprehensive Guide to Nootropics 


